Ophthalmology and Optometry Coding Alert

Optometry/Ophthalmology Coding:

Use This Guide to Identify the Correct AMD ICD-10-CM Codes

Do you need multiple codes for separate AMD diagnoses in each eye?

Age-related macular degeneration (AMD) is a progressive retinal disease and one of the leading causes of vision loss among individuals age 50 and older. Accurate ICD-10-CM coding for AMD is essential for proper documentation, reimbursement, quality reporting, and risk adjustment.

Read on to learn more about this condition and how to code diagnoses correctly.

Get an Overview of AMD

AMD presents in multiple forms and stages, which means your coding requires careful attention to laterality, disease type, and severity. Understanding the structure of the ICD-10-CM codes for AMD ensures precise reporting and reduces the risk of claim denials or compliance concerns.

AMD affects the macula, the central portion of the retina responsible for sharp, detailed vision.

The primary types of AMD include:

  • Nonexudative (dry) AMD: This condition is characterized by yellow-colored lipid and protein deposits, known as drusen, and geographic atrophy. Dry AMD typically progresses more slowly than wet AMD.
  • Exudative (wet) AMD: This condition is characterized by choroidal neovascularization (CNV), leading to leakage, bleeding, and more rapid central vision loss.

ICD-10-CM classifies AMD under the H35.3- (Degeneration of macula and posterior pole) category, with specific subcategories identifying the type and stage of the disease.

OCT eye scan imaging at an ophthalmology clinic. Girl undergoes a retina exam using optical coherence tomograph.

Identify the AMD ICD-10-CM Code Structure

The primary codes for AMD fall within the H35.31- (Nonexudative age-related macular degeneration) to H35.32- (Exudative age-related macular degeneration) subcategories.

Each subcategory requires additional characters to identify laterality, stage or severity for nonexudative AMD, and disease activity for exudative AMD.

Accurate coding depends on complete provider documentation specifying these details.

Code Dry AMD Diagnoses

Nonexudative AMD codes require identification of the stage of disease; these stages are early dry AMD, intermediate dry AMD, advanced atrophic without subfoveal involvement, and advanced atrophic with subfoveal involvement.

Examples of these codes include:

  • H35.3111 (Nonexudative age-related macular degeneration, right eye, early dry stage)
  • H35.3123 (Nonexudative age-related macular degeneration, left eye, advanced atrophic without subfoveal involvement)
  • H35.3134 (Nonexudative age-related macular degeneration, bilateral, advanced atrophic with subfoveal involvement)

The distinction between the advanced atrophic stages with or without subfoveal involvement is clinically significant because subfoveal involvement indicates central vision impact and may influence management decisions and medical necessity for services.

Coders must rely on explicit provider documentation regarding stage. If the stage is not documented, an unspecified stage code may be used; however, this should be avoided when more specific documentation is available.

Know When to Report Wet AMD Diagnosis Codes

Exudative AMD codes focus on disease activity rather than stage. The classification distinguishes between active CNV, inactive CNV, inactive scar, and unspecified activity.

Examples of exudative AMD codes with stage classification include:

  • H35.3211 (Exudative age-related macular degeneration, right eye, with active choroidal neovascularization)
  • H35.3222 (Exudative age-related macular degeneration, left eye, with inactive choroidal neovascularization)
  • H35.3233 (Exudative age-related macular degeneration, bilateral, with inactive scar)

Active CNV typically corresponds to ongoing leakage or bleeding requiring treatment such as intravitreal anti-VEGF injections. VEGF stands for vascular endothelial growth factor, which is a protein found in the cells of the body that produces new blood vessels when needed. Inactive CNV indicates previously treated or stabilized disease without current activity, while an inactive scar reflects permanent fibrotic damage.

Clear documentation of disease activity is critical for accurate coding.

Nail Down Laterality Requirements

ICD-10-CM requires a 6th character to report laterality; the characters represent right eye, left eye, bilateral, or unspecified eye.

If a patient has different stages or types of AMD in each eye, separate codes must be assigned. For example, a patient may have intermediate dry AMD in the right eye and exudative AMD with active CNV in the left eye. Both conditions will be coded individually with the appropriate laterality and classification.

Failure to capture laterality accurately can lead to claim denials, particularly when billing for procedures performed on a specific eye.

Recognize Documentation Considerations

Clinical documentation should clearly include the type of AMD, the stage for nonexudative (dry) AMD, disease activity for exudative (wet) AMD, laterality, and any relevant treatment such as anti-VEGF injections.

Diagnostic tests such as optical coherence tomography (OCT) may support the provider’s clinical assessment; however, code assignment must be based on the provider’s documented diagnosis. When documentation does not clearly specify the stage or activity of the disease, you may need to query the provider to obtain the level of specificity required for accurate ICD-10-CM code assignment.

Avoid These Common Coding Pitfalls

Several common errors occur in AMD coding, such as:

  • Using unspecified codes when specificity is documented
  • Failing to report bilateral disease correctly
  • Not coding each eye separately when disease types differ
  • Confusing inactive CNV with inactive scar
  • Assigning exudative AMD without documented CNV

Careful review of the provider’s assessment and plan typically provides the most precise diagnostic language for accurate code selection.

Examine Risk Adjustment and Medical Necessity

Exudative AMD codes, particularly those indicating active disease, may impact risk adjustment models that reflect patient acuity. Proper code specificity helps ensure accurate representation of the patient’s condition.

Detailed coding also supports medical necessity for services such as intravitreal injections, OCT, fluorescein angiography, and photodynamic therapy.

Incomplete or inaccurate coding can create discrepancies between diagnoses and procedures, increasing audit risk.

Conclusion

ICD-10-CM coding for AMD requires careful attention to disease type, stage or activity, laterality, and documentation specificity. The classification system reflects important clinical distinctions that directly affect treatment and prognosis.

Accurate coding supports appropriate reimbursement, strengthens compliance efforts, and improves data integrity for quality reporting. For coders and compliance professionals, understanding the nuances within the H35.31- and H35.32- categories is essential for proper reporting of AMD in ophthalmology practices.

Rebecca Greenlaw, CPC, CPCO, COPC, Coding and Reimbursement Consultant,
Corcoran Consulting Group